JEAN VILLIER: Open Payments
NPI 1649212200 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 34 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $207 · 2025 $627
Food & beverage: $615Education: $12
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $182 |
| Vanda Pharmaceuticals Inc. | 7 | $179 |
| Alkermes, Inc. | 9 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: COBENFY, FANAPT, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, INGREZZA.
Industry payments across DC — which companies pay providers there.
